a developer of synthetic vaccines and immune therapies for cancers and infectious diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, INO has been loosely correlated with ONCO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then ONCO could also see price increases.
Ticker / NAME | Correlation To INO | 1D Price Change % | ||
---|---|---|---|---|
INO | 100% | -10.94% | ||
ONCO - INO | 43% Loosely correlated | -5.15% | ||
PCSA - INO | 38% Loosely correlated | +2.17% | ||
VERA - INO | 37% Loosely correlated | +1.43% | ||
VOR - INO | 33% Poorly correlated | -4.68% | ||
ACET - INO | 32% Poorly correlated | +2.05% | ||
More |
Ticker / NAME | Correlation To INO | 1D Price Change % |
---|---|---|
INO | 100% | -10.94% |
cancer theme (87 stocks) | 39% Loosely correlated | +0.89% |
covid-19 vaccine theme (6 stocks) | 37% Loosely correlated | +3.31% |
immune theme (11 stocks) | 36% Loosely correlated | +1.62% |
drugs theme (265 stocks) | 34% Loosely correlated | +5.37% |
diseases theme (42 stocks) | 34% Loosely correlated | +1.03% |
More |